1,692
Views
37
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Efficacy of Tiotropium in COPD Patients with FEV1 ≥ 60% Participating in the UPLIFT® Trial

, , , , &
Pages 289-296 | Published online: 20 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jeong Uk Lim, Kyungjoo Kim, Sang Hyun Kim, Myung Goo Lee, Sang Yeub Lee, Kwang Ha Yoo, Sang Haak Lee, Ki-Suck Jung, Chin Kook Rhee & Yong Il Hwang. (2017) Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2711-2721.
Read now
F. J. Callejas González, M. Genovés Crespo, J. Cruz Ruiz, R. Godoy Mayoral, F. J. Agustín Martínez, A. J. Martínez García & P. J. Tárraga López. (2016) UPLIFT study - understanding potential long-term impacts on function with tiotropium - and sub-analyses. Bibliographic resume of the obtained results. Expert Review of Respiratory Medicine 10:9, pages 1023-1033.
Read now
Ha Youn Lee, Sun Mi Choi, Jinwoo Lee, Young Sik Park, Chang-Hoon Lee, Deog Kyeom Kim, Sang-Min Lee, Ho Il Yoon, Jae-Joon Yim, Young Whan Kim, Sung Koo Han & Chul-Gyu Yoo. (2015) Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2185-2192.
Read now
Soichiro Hanada, Shota Wada, Takeshi Ohno, Hirochiyo Sawaguchi, Masato Muraki & Yuji Tohda. (2015) Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 69-77.
Read now
Ronald Dahl, Dalal Jadayel, Vijay KT Alagappan, Hungta Chen & Donald Banerji. (2013) Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 501-508.
Read now

Articles from other publishers (32)

Esperanza Doña, Rocío Reinoso-Arija, Laura Carrasco-Hernandez, Adolfo Doménech, Antonio Dorado & José Luis Lopez-Campos. (2023) Exploring Current Concepts and Challenges in the Identification and Management of Early-Stage COPD. Journal of Clinical Medicine 12:16, pages 5293.
Crossref
Dave Singh, Diego Litewka, Rafael Páramo, Adrian Rendon, Abdullah Sayiner, Suzana E. Tanni, Sudeep Acharya, Bhumika Aggarwal, Afisi S. Ismaila, Raj Sharma & Peter Daley-Yates. (2023) DElaying Disease Progression In COPD with Early Initiation of Dual Bronchodilator or Triple Inhaled PharmacoTherapy (DEPICT): A Predictive Modelling Approach. Advances in Therapy.
Crossref
Hideyasu Yamada, Isao Matsumoto, Naoyuki Makita, Yoshifumi Arita, Nobuya Hayashi, Kurena Mitsuoka, Naoki Tashiro & Nobuyuki Hizawa. (2022) Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study. Respiratory Research 23:1.
Crossref
Björn Lemmer. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021 361 377 .
Antonio Anzueto & Marc Miravitlles. (2020) Tiotropium in chronic obstructive pulmonary disease – a review of clinical development. Respiratory Research 21:1.
Crossref
José Luis López-Campos. 2020. Precision Medicine for Investigators, Practitioners and Providers. Precision Medicine for Investigators, Practitioners and Providers 369 379 .
Björn Lemmer. 2020. Arzneiverordnungs-Report 2020. Arzneiverordnungs-Report 2020 455 471 .
Dave Singh, Anthony D. D’Urzo, James F. Donohue & Edward M. Kerwin. (2019) Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective. Respiratory Research 20:1.
Crossref
Robert M. Burkes & Michael B. Drummond. (2019) Initiating drug therapy in early stage chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 25:2, pages 132-137.
Crossref
Chenglong Li, Yumin Zhou, Sha Liu, Mengning Zheng, Jinzhen Zheng, Huanhuan Peng, Zhishan Deng, Nanshan Zhong & Pixin Ran. (2019) Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study. ERJ Open Research 5:1, pages 00175-2018.
Crossref
Björn Lemmer. 2019. Arzneiverordnungs-Report 2019. Arzneiverordnungs-Report 2019 595 611 .
Mario Cazzola & Paola Rogliani. (2018) Tiotropium could provide benefits in the early stage of COPD, but further studies are needed. BMJ Evidence-Based Medicine 23:5, pages 183-184.
Crossref
Jose Luis Lopez-Campos, Laura Carrasco Hernández, Xavier Muñoz, Víctor Bustamante & Esther Barreiro. (2018) Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level. Respirology 23:9, pages 818-827.
Crossref
Jamuna K. Krishnan & Fernando J. Martinez. (2018) Lung function trajectories and chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 24:2, pages 124-129.
Crossref
Björn Lemmer. 2018. Arzneiverordnungs-Report 2018. Arzneiverordnungs-Report 2018 453 466 .
Yumin Zhou, Nan-shan Zhong, Xiaochen Li, Shuyun Chen, Jinping Zheng, Dongxing Zhao, Weimin Yao, Rongchang Zhi, Liping Wei, Bingwen He, Xiangyan Zhang, Changli Yang, Ying Li, Fenglei Li, Juan Du, Jianping Gui, Bin Hu, Chunxue Bai, Ping Huang, Gang Chen, Yongjian Xu, Changzheng Wang, Biao Liang, Yinhuan Li, Guoping Hu, Hui Tan, Xianwei Ye, Xitao Ma, Yan Chen, Xiwei Hu, Jia Tian, Xiaodan Zhu, Zhe Shi, Xiufang Du, Minjing Li, Shengming Liu, Ronghuan Yu, Jianping Zhao, Qianli Ma, Canmao Xie, Xiongbin Li, Tao Chen, Yingxiang Lin, Lizhen Zeng, Changxiu Ye, Weishu Ye, Xiangwen Luo, Lingshan Zeng, Shuqing Yu, Wei-jie Guan & Pixin Ran. (2017) Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. New England Journal of Medicine 377:10, pages 923-935.
Crossref
Fanny W.S. Ko & Gary W.K. Wong. (2017) Drug Treatment for Early-Stage COPD. New England Journal of Medicine 377:10, pages 988-989.
Crossref
José Luis Lopez-Campos, Eduardo Marquez-Martín & Francisco Ortega-Ruiz. (2017) Cambios mayores en la Guía española de la EPOC (GesEPOC) 2017: cruzando puentes. Archivos de Bronconeumología 53:6, pages 291-292.
Crossref
José Luis Lopez-Campos, Eduardo Marquez-Martín & Francisco Ortega-Ruiz. (2017) Major Changes in the Spanish COPD Guidelines (GesEPOC) 2017: Crossing Bridges. Archivos de Bronconeumología (English Edition) 53:6, pages 291-292.
Crossref
Mark T. Dransfield, Ken M. Kunisaki, Matthew J. Strand, Antonio Anzueto, Surya P. Bhatt, Russell P. Bowler, Gerard J. Criner, Jeffrey L. Curtis, Nicola A. Hanania, Hrudaya Nath, Nirupama Putcha, Sarah E. Roark, Emily S. Wan, George R. Washko, J. Michael Wells, Christine H. Wendt & Barry J. Make. (2017) Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 195:3, pages 324-330.
Crossref
Björn Lemmer. 2017. Arzneiverordnungs-Report 2017. Arzneiverordnungs-Report 2017 403 416 .
Li An, Yingxiang Lin, Ting Yang & Lin Hua. (2016) Exploring the interaction among EPHX1, GSTP1, SERPINE2, and TGFB1 contributing to the quantitative traits of chronic obstructive pulmonary disease in Chinese Han population. Human Genomics 10:1.
Crossref
Jung Yeon LeeChin Kook RheeKi Suck JungKwang Ha Yoo. (2016) Strategies for Management of the Early Chronic Obstructive Lung Disease. Tuberculosis and Respiratory Diseases 79:3, pages 121.
Crossref
Björn Lemmer. 2016. Arzneiverordnungs-Report 2016. Arzneiverordnungs-Report 2016 399 412 .
Mitsuhiro Yamada & Masakazu Ichinose. (2015) Cutting edge of COPD therapy: current pharmacological therapy and future direction. COPD Research and Practice 1:1.
Crossref
Puja Kohli, Victor Pinto-Plata, Miguel Divo, Atul Malhotra, R. Scott Harris, Aili Lazaar, Aiden Flynn, Ruth Tal-Singer, Reynold A. Panettieri & Bartolome Celli. (2015) Functional Capacity, Health Status, and Inflammatory Biomarker Profile in a Cohort of Patients With Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation and Prevention 35:5, pages 348-355.
Crossref
T. Welte, C. Vogelmeier & A. Papi. (2015) COPD: early diagnosis and treatment to slow disease progression. International Journal of Clinical Practice 69:3, pages 336-349.
Crossref
Björn Lemmer. 2015. Arzneiverordnungs-Report 2015. Arzneiverordnungs-Report 2015 547 568 .
Kayleigh M Kew, Sofia Dias & Christopher J Cates. (2014) Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database of Systematic Reviews.
Crossref
Donald P Tashkin. (2013) Tiotropium for the treatment of chronic obstructive pulmonary disease. Clinical Practice 10:2, pages 141-155.
Crossref
Judith A Brebner. (2013) Early chronic obstructive pulmonary disease : Beyond spirometry. World Journal of Respirology 3:3, pages 57.
Crossref
Björn Lemmer. 2013. Arzneiverordnungs-Report 2013. Arzneiverordnungs-Report 2013 485 502 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.